Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF-Endoret in Knee Osteoarthritis
NCT03160781Phase 2Completed
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Cell Therapies
01
Overview
Phase 2, open-label, single-arm trial of PRGF-Endoret in knee osteoarthritis (OA). Primary endpoint: Knee Injury and Osteoarthritis Outcome Score Pain at 6 months. Started Jan 2014; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03160781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03160781.